InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,481.45
(
0.31%
)
US TECH 100
19,110.40
(
-0.50%
)
Dow Jones
39,492.42
(
0.87%
)
Brent Oil
85.24
(
1.45%
)
Bitcoin
60,740.60
(
-3.83%
)
Post# of 252318
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 99112

Tuesday, 07/20/2010 12:31:52 PM

Tuesday, July 20, 2010 12:31:52 PM

Post# of 252318
Once-daily Kaletra was approved end of Apr for treatment in experienced patients, so the downfall might slow a bit. Reyataz is already the leading PI and Prezista is a tough competitor but I think Isentress might be less of a competitor due to low barrier to resistance. On the big picture I agree with ciotera - the trend is not in favor for Kaletra.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up